Gerald Miller

1.7k total citations
45 papers, 1.3k citations indexed

About

Gerald Miller is a scholar working on Hematology, Surgery and Genetics. According to data from OpenAlex, Gerald Miller has authored 45 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 6 papers in Surgery and 6 papers in Genetics. Recurrent topics in Gerald Miller's work include Blood groups and transfusion (8 papers), Erythrocyte Function and Pathophysiology (6 papers) and Hemoglobinopathies and Related Disorders (5 papers). Gerald Miller is often cited by papers focused on Blood groups and transfusion (8 papers), Erythrocyte Function and Pathophysiology (6 papers) and Hemoglobinopathies and Related Disorders (5 papers). Gerald Miller collaborates with scholars based in United States, Israel and United Kingdom. Gerald Miller's co-authors include David Martin, Narumol Chinookoswong, Frank Hinman, William A. Greene, Deborah Russell, David P. Martin, Edward Shatzen, Kurt I. Altman, Mary S. Rosendahl and James B. MacWhinney and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

Gerald Miller

44 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerald Miller United States 21 218 213 187 184 167 45 1.3k
Juan F. Sotos United States 21 111 0.5× 631 3.0× 165 0.9× 47 0.3× 178 1.1× 48 1.5k
Hiroyasu Ishikawa Japan 20 71 0.3× 238 1.1× 107 0.6× 141 0.8× 81 0.5× 92 1.5k
B. Lang Germany 27 54 0.2× 153 0.7× 196 1.0× 49 0.3× 38 0.2× 74 2.0k
Roy Moncayo Austria 28 53 0.2× 193 0.9× 269 1.4× 69 0.4× 125 0.7× 109 2.7k
J. Jones United Kingdom 21 108 0.5× 261 1.2× 601 3.2× 38 0.2× 164 1.0× 61 1.6k
Haruhide Ito Japan 28 23 0.1× 466 2.2× 237 1.3× 339 1.8× 155 0.9× 128 2.7k
B Rajagopalan United Kingdom 17 70 0.3× 317 1.5× 68 0.4× 183 1.0× 100 0.6× 44 1.3k
J. B. Posner United States 17 50 0.2× 211 1.0× 631 3.4× 364 2.0× 78 0.5× 20 2.3k
Scott B. Perlman United States 30 47 0.2× 171 0.8× 634 3.4× 124 0.7× 60 0.4× 110 2.6k
Antonio Agostino Sinisi Italy 36 57 0.3× 639 3.0× 386 2.1× 89 0.5× 106 0.6× 118 3.3k

Countries citing papers authored by Gerald Miller

Since Specialization
Citations

This map shows the geographic impact of Gerald Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald Miller more than expected).

Fields of papers citing papers by Gerald Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald Miller. The network helps show where Gerald Miller may publish in the future.

Co-authorship network of co-authors of Gerald Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald Miller. A scholar is included among the top collaborators of Gerald Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald Miller. Gerald Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miller, Gerald, et al.. (2011). Cinacalcet HCl prevents development of parathyroid gland hyperplasia and reverses established parathyroid gland hyperplasia in a rodent model of CKD. Nephrology Dialysis Transplantation. 27(6). 2198–2205. 33 indexed citations
2.
Miller, Gerald, Ryan M. Briggs, & Harry A. Atwater. (2010). Achieving optical gain in waveguide-confined nanocluster-sensitized erbium by pulsed excitation. Journal of Applied Physics. 108(6). 15 indexed citations
3.
Feng, Tao, Gerald Miller, & Harry A. Atwater. (2007). Charge retention characteristics of silicon nanocrystal layers by ultrahigh vacuum atomic force microscopy. Journal of Applied Physics. 102(3). 2 indexed citations
4.
Shatzen, Edward, Gerald Miller, Catherine Stehman‐Breen, et al.. (2005). Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism. Kidney International. 67(2). 467–476. 130 indexed citations
5.
Miller, Gerald, et al.. (1999). Prophylactic Antibiotics in Recurrent Parotitis in a Patient with Sjogren's Syndrome. Clinical Rheumatology. 18(2). 163–164. 3 indexed citations
6.
Raghupathi, Ramesh, et al.. (1999). Interleukin-1 Receptor Antagonist Attenuates Regional Neuronal Cell Death and Cognitive Dysfunction after Experimental Brain Injury. Journal of Cerebral Blood Flow & Metabolism. 19(10). 1118–1125. 86 indexed citations
7.
Miller, Gerald, et al.. (1998). Radiation therapy in the management of malignant gliomas. Reports of Practical Oncology & Radiotherapy. 3(1). 13–17. 1 indexed citations
8.
Martin, David, et al.. (1996). Intranigral or intrastriatal injections of GDNF: effects on monoamine levels and behavior in rats. European Journal of Pharmacology. 317(2-3). 247–256. 47 indexed citations
10.
Miller, Gerald, et al.. (1995). Potent inhibitory effects of glial derived neurotrophic factor against kainic acid mediated seizures in the rat. Brain Research. 683(2). 172–178. 86 indexed citations
11.
Martin, David, Narumol Chinookoswong, & Gerald Miller. (1994). The Interleukin-1 Receptor Antagonist (rhIL-1ra) Protects against Cerebral Infarction in a Rat Model of Hypoxia-Ischemia. Experimental Neurology. 130(2). 362–367. 140 indexed citations
12.
Miller, Gerald. (1993). The Impacts of Antitrust Enforcement on Industry Performance. 1 indexed citations
13.
Miller, Gerald. (1972). The diagnosis of the carcinoma of the stomach in its early phase. I.. PubMed. 61(4). 279–84. 2 indexed citations
14.
George, James N., Gerald Miller, & Robert T. Breckenridge. (1971). Studies on Christmas Disease: Investigation and Treatment of a Familial Acquired Inhibitor of Factor IX. British Journal of Haematology. 21(3). 333–342. 4 indexed citations
15.
Townes, Philip L., et al.. (1967). Further observations on trypsinogen deficiency disease: Report of a second case. The Journal of Pediatrics. 71(2). 220–224. 31 indexed citations
16.
Punnett, Hope H., et al.. (1964). Serial cytogenetic and hematologic studies on amongol with trisomy-21 and acute congenital leukemia. The Journal of Pediatrics. 65(6). 880–887. 57 indexed citations
17.
Miller, Gerald, et al.. (1964). ACUTE INFECTIOUS LYMPHOCYTOSIS PRESENTING AS A PERTUSSIS-LIKE ILLNESS: ITS ASSOCIATION WITH ADENOVIRUS TYPE 12. The Lancet. 283(7326). 200–201. 30 indexed citations
18.
Greene, William A. & Gerald Miller. (1958). Psychological Factors and Reticuloendothelial Disease. Psychosomatic Medicine. 20(2). 124–144. 67 indexed citations
19.
Young, Lawrence E., Gerald Miller, & Scott N. Swisher. (1957). Treatment of hemolytic disorders. Journal of Chronic Diseases. 6(4-5). 307–323. 5 indexed citations
20.
Miller, Gerald, et al.. (1955). HEMOLYTIC DISEASE OF THE NEWBORN DUE TO ANTI-A AND ANTI-B. PEDIATRICS. 15(1). 54–62. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026